Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-dose capsaicin (0.01 mM) nasal spray is equally effective as the current standard treatment for idiopathic rhinitis: A randomized, double-blind, placebo-controlled trial.
Van Gerven L, Steelant B, Cools L, Callebaut I, Backaert W, de Hoon J, Ampe E, Talavera K, Hellings PW. Van Gerven L, et al. Among authors: hellings pw. J Allergy Clin Immunol. 2021 Jan;147(1):397-400.e4. doi: 10.1016/j.jaci.2020.04.054. Epub 2020 May 19. J Allergy Clin Immunol. 2021. PMID: 32439432 No abstract available.
Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis.
Van Gerven L, Alpizar YA, Wouters MM, Hox V, Hauben E, Jorissen M, Boeckxstaens G, Talavera K, Hellings PW. Van Gerven L, et al. Among authors: hellings pw. J Allergy Clin Immunol. 2014 May;133(5):1332-9, 1339.e1-3. doi: 10.1016/j.jaci.2013.08.026. Epub 2013 Oct 15. J Allergy Clin Immunol. 2014. PMID: 24139494
Enhanced chemosensory sensitivity in patients with idiopathic rhinitis and its reversal by nasal capsaicin treatment.
Van Gerven L, Alpizar YA, Steelant B, Callebaut I, Kortekaas Krohn I, Wouters M, Vermeulen F, Boeckxstaens G, Talavera K, Hellings PW. Van Gerven L, et al. Among authors: hellings pw. J Allergy Clin Immunol. 2017 Aug;140(2):437-446.e2. doi: 10.1016/j.jaci.2017.03.014. Epub 2017 Apr 4. J Allergy Clin Immunol. 2017. PMID: 28389389 Clinical Trial.
Epithelial barriers in allergy and asthma.
Hellings PW, Steelant B. Hellings PW, et al. J Allergy Clin Immunol. 2020 Jun;145(6):1499-1509. doi: 10.1016/j.jaci.2020.04.010. J Allergy Clin Immunol. 2020. PMID: 32507228 Free PMC article. Review.
Epithelial and sensory mechanisms of nasal hyperreactivity.
Velasco E, Delicado-Miralles M, Hellings PW, Gallar J, Van Gerven L, Talavera K. Velasco E, et al. Among authors: hellings pw. Allergy. 2022 May;77(5):1450-1463. doi: 10.1111/all.15259. Epub 2022 Feb 26. Allergy. 2022. PMID: 35174893 Review.
Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression.
Steelant B, Farré R, Wawrzyniak P, Belmans J, Dekimpe E, Vanheel H, Van Gerven L, Kortekaas Krohn I, Bullens DMA, Ceuppens JL, Akdis CA, Boeckxstaens G, Seys SF, Hellings PW. Steelant B, et al. Among authors: hellings pw. J Allergy Clin Immunol. 2016 Apr;137(4):1043-1053.e5. doi: 10.1016/j.jaci.2015.10.050. Epub 2016 Feb 2. J Allergy Clin Immunol. 2016. PMID: 26846377 Free article. Clinical Trial.
320 results